Sunnyvale, April 22, 2019 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, announces that its national network of allergy testing services clinics has nearly quadrupled in 9 months to more than 700 clinics, and now comprises all seven major geographical regions and the majority of the 50 United States. Arrayit finger stick allergy testing services empower doctors to identify, treat and manage allergy and asthma from a few drops of patient blood. Anti-aging, back pain and sciatica, chiropractic care, dermatology, digestive health, ear nose and throat (ENT), family medicine, gastroenterology, health and beauty, immunology, integrative medicine, internal medicine, obesity, obstetrics and gynecology (OB-GYN), pain relief, pediatrics, personalized medicine, preventative medicine, primary care, rehabilitation, sinus, spinal care, urgent care, weight loss, wellness and women's health clinics are among the medical specialties represented in the 700-clinic Arrayit network.
Arrayit recently completed an allergy testing pilot program for a top retail chain, established a nationwide network of 1,700 allergy sales professionals, met with top officials at the United States Food and Drug Administration (FDA) regarding approval of a major product line, fulfilled an FDA clinical instrumentation contract, received approval for in-store promotions by a major retailer, announced allergy testing partnerships with major allergy therapeutics providers, received approval for direct Medicare billing by the Centers for Medicare and Medicaid Services, launched the Patient Data Solutions allergy portal for doctors and clinics, celebrated 25 years of company operations, announced an allergy testing services agreement with a major health and wellness provider, provided a letter to shareholders from the company’s Chief Executive Officer, aced four consecutive rounds of proficiency testing, received endorsement by First Pediatrics Medical Group, doubled the number of clinics in its nationwide network to more than 400, announced in-network allergy testing services contracting with a top five commercial health benefits company, doubled its weekly billing guidance, appointed an Apple enterprise healthcare partner to accelerate revenues and earnings growth and expanded allergy testing services evaluation with a major retail pharmacy chain. Fiscal year 2019 (FY2019) revenues and earnings are likely to see a significant positive impact from the expanding network of 700 clinics.
CEO Rene Schena states, “We are pleased to announce the continued expansion of our allergy testing services healthcare network on a national scale as an important step towards empowering physicians to improve the health and wellness of 60 million American allergy and asthma patients. The 700 clinics in our growing network leverage convenient finger stick blood sampling, rapid turnaround times and highly automated on-line ordering to create a modern, high-tech healthcare experience.”
Arrayit Corporation, headquartered in Sunnyvale, California, leads and empowers the research, biotechnology, pharmaceutical, clinical and healthcare sectors through the discovery, development and manufacture of proprietary life science and personalized medicine products and services to advance biomedical research and improve human health and wellness. Please visit www.arrayit.com for more information.
Safe Harbor Statement
We have identified forward-looking statements by using words such as "expect", "believe", “would". Although we believe our expectations are reasonable, our operations involve a number of risks and uncertainties that are beyond our control, and these statements may turn out not to be true. Risk factors associated with our business, including some of the facts set forth herein, are detailed in the Company's public filings.